CTRI/2018/05/013733
Recruiting
未知
Antifungal Drug Utilization in Selected Clinical Care Settings of a Tertiary Care Teaching Hospital
ConditionsHealth Condition 1: null- ICU patients
Overview
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- KEM Hospital
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •1\. Patients admitted in either MICU, PICU or in Hematology ward and receiving antifungal drugs as a part of his/her treatment.
- •2\. Patients or LAR willing to give informed consent
Exclusion Criteria
- •1\. Re\-consent refusal from patient, after regaining consciousness when admitted in unconscious state
- •2\. Patients receiving prophylactic antifungal therapy
Investigators
Similar Trials
Not yet recruiting
Not Applicable
A descriptive study regarding use of antifungal agents in critically ill patientsCTRI/2024/06/069514ASHIQUE ALI N K
Completed
Not Applicable
Clinical investigation of anti-fungal strategies in patients under aggressive treatment of hematological malignanciesZ94.80B44C92D46.9AspergillosisMyeloid leukaemiaMyelodysplastic syndrome, unspecifiedDRKS00000347niklinik Freiburg Häm/Onk220
Not yet recruiting
Not Applicable
Clinicomycological study and efficacy of antifungal treatment in dernatophytosis.Health Condition 1: - Health Condition 2: L089- Local infection of the skin and subcutaneous tissue, unspecifiedCTRI/2020/03/023959GMERS Medical College And Hospital Gotri
Completed
Phase 4
Antifungal Use in Oncohematological Neutropenic PatientsInvader Fungal InfectionNCT00386802PETHEMA Foundation115
Active, not recruiting
Phase 1
Empirical versus pre-emptive antifungal therapy of patients withhaematological malignanciesEmpirical versus pre-emptive (diagnosticdriven)antifungal therapy of patients treated for haematological malignancies or receiving an allogeneic stem cell transplant. A therapeutic open label phase IIIstrategy study of the EORTC Infectious Diseases and Leukemia Groups.Invasive fungal infection in patients with hematological malignancies.MedDRA version: 14.1Level: LLTClassification code 10017544Term: FungemiaSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2010-020814-27-NLEORTC556